REGN
Regeneron Pharmaceuticals Inc
796.00$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.2% | +38.8% | -76.6% | +264.7% | -2.2% | -17.2% | +9.5% | +41.4% | -27.7% | -7.8% | -46.8% | – | |
| – | +7.2% | +1.0% | +5.8% | +0.8% | +3.9% | +0.4% | +6.5% | +1.2% | +6.1% | -15.0% | +0.4% | – | |
| – | +17.9% | -4.3% | -3.0% | +0.9% | +35.2% | -16.0% | -1.6% | -5.8% | +5.2% | +3.2% | -5.6% | – | |
| – | – | – | -306.2% | – | -118.5% | – | -275.8% | – | -99.1% | -1,411.9% | – | – | |
| – | +78.1% | -48.4% | +30.3% | -12.9% | +45.4% | +1.7% | -34.9% | +13.9% | +23.5% | -7.3% | +4.2% | – | |
| – | -86.7% | +2,448.5% | -67.0% | +3.1% | – | +84.7% | -269.0% | -63.2% | – | -294.7% | -78.4% | – | |
| – | – | – | – | – | – | – | -1.3% | -1.5% | +1.6% | +5.5% | -1.0% | – | |
| – | +10.5% | -61.0% | +107.3% | +21.7% | +32.4% | +7.5% | +1.5% | -37.4% | +1.2% | +18.3% | +47.2% | – | |
| – | +9.5% | – | -1,115.1% | +32.6% | +79.1% | -4.1% | +3.6% | -36.4% | +8.7% | +2.8% | +192.3% | – | |
| – | +174.4% | -122.2% | – | – | +470.8% | +26.6% | -278.4% | – | +22.7% | -125.1% | – | – | |
| – | -17.3% | +74.0% | -89.4% | +674.0% | -10.1% | -22.3% | +25.1% | +46.5% | -34.9% | -8.0% | -60.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.